首页 | 本学科首页   官方微博 | 高级检索  
     

三氧化二砷抑制肝癌细胞增殖的体内实验研究
引用本文:唐印华 刘铁夫 等. 三氧化二砷抑制肝癌细胞增殖的体内实验研究[J]. 哈尔滨医药, 2003, 23(1): 3-4
作者姓名:唐印华 刘铁夫 等
作者单位:哈尔滨医科大学附属第一医院 150001(唐印华,刘铁夫,庄丽维,姜爱民),哈尔滨医科大学附属第一医院 150001(梁桃)
摘    要:目的:探讨As2O3对小鼠H22肝癌细胞增殖的抑制作用。方法:建立小鼠H22肝癌实体型移植瘤模型,腹腔应用As2O3治疗后,通过PCNA及CyclinD1免疫组化检测指标反映细胞增殖改变。结果:As2O3能够下调PCNA及CyclinD1蛋白的表达。结论:As2O3对小鼠肝癌细胞的增殖具有明显的抑制作用,具有治疗肝癌潜在价值。

关 键 词:实验研究 三氧化二砷 肝癌 移植 免疫组织化学

In vivo study on proliferation inhibition by arsenic trioxide in liver cancer
Tang yinhua Liu tiefu,et al.. In vivo study on proliferation inhibition by arsenic trioxide in liver cancer[J]. harbin medical journal, 2003, 23(1): 3-4
Authors:Tang yinhua Liu tiefu  et al.
Affiliation:Tang yinhua Liu tiefu,et al. Department of digestive First affiliated hospital Harbin Medical University. Harbin,150001)
Abstract:Objective To explore the inhibition of proliferation by arsenic trioxide(As2O3) in mice liver cancer. Methods Mice bearing H22 solid liver cancer cells were treated with defferent density arsenic triox-ide. PCNA and CyclinD1 of tumor cells were studied by immunohistochemical methods. Results PCNA and CyclinD1 positive cells of As2O3 - treated groups were obviously lower than those of controls. Conclusion Animal experiment proved that As2O3 can obviously inhibit the proliferation of mice H22 liver cancer cells.
Keywords:arsenic trioxide hepatoma transplant immunohistochemistry
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号